FdaApplication

NDA 021205

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVIIV HEALTHCARE CO
application_typeNDA
approval_date2000-11-14

Products (1)

ProductActive ingredientStrengthDosage form
TRIZIVIRABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINEEQ 300MG BASE;150MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

1 product